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Most outcomes do not deeply express the degree of disability in patients with respiratory
failure (RF) following inpatient pulmonary rehabilitation (IPR). The aim of our study was to
evaluate the efficacy of an IPR in patients with confirmed COPD and RF using functional inde-
pendence measure (FIM) that determines the degree of disability experienced by patients and
the progress they make during rehabilitation. This scale includes several items: self care,
mobility, locomotion, communication and social recognition.
Twenty-two patients (age 70 2 years, PO2 58.18 7.63 mmHg, PCO2 46.82 9.11 mmHg)
were prospectively observed and studied. IPR included respiratory and peripheral muscle
training, mucus evacuation techniques, and energy conservation techniques. FIM, Medical
Research Council dyspnoea scale (MRC), St. George’s Respiratory Questionnaire (SGRQ), and
6-min walking distance (6-MWD) were assessed on admission (pre) and discharge (post) from
IPR.
After IPR there was a statistically significant improvement (p< 0.01) in all the FIM items
(total score in self care, mobility, locomotion, social recognition) except for communication.
Changes of MRC (pre 4.32 0.84; post 3.00 1.15, p< 0.001), SGRQ (%) (pre 69.86 4.62; post
46.50 11.94, p< 0.001), and 6-MWD (pre 164.54 98.63; post 214.32 97.64, p< 0.001) par-
alleled those improvements. An inverse correlation between MRC and FIM (rZ 0.5042,
pZ 0.016) was observed.961041.
.it (G.L. Biscione).
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472 F. Pasqua et al.Our preliminary study has shown that the benefits of IPR in COPD with RF do not only trans-
late in dyspnoea, exercise capacity and quality of life but also within neuromotor disabilities
as assessed by FIM. Our results warrant future studies in pulmonary rehabilitation using FIM as
an outcome measure.
ª 2008 Elsevier Ltd. All rights reserved.Table 1 Demographic, anthropometric and functional
characteristics of patients at study entry
Parameter Mean SD
Number 22
Males/females 15/7
Age (years) 70.36 11.58
FIM e total score 92.18 23.29
FEV1 (% predicted) 48.8 6.4
PaO2 (mmHg) 58.18 7.63
PCO2 (mmHg) 46.82 9.11
6-MWT (m) 164.55 98.63
MRC 4.32 0.84
SGRQ e total score 69.86 14.62
LTOT (%) 100
Patients with tracheotomy 4
CI 3.95 2.1
Bed rest (days) 26.4 10.5
Patients weaned from MV 12
Patients undergoing NIMV 6
Disease history (years) 23.1 8.55
Patients sent from ICU 6
Patients sent from RICU 8
Patients sent from other wards 8
Data are provided as means (SD).Introduction
Chronic obstructive pulmonary disease (COPD) is a major
cause of morbidity and mortality in the Western world1 and
mortality rates are on the rise2; it is characterised by
a progressive deterioration of respiratory function over time
with systemic effects which leads to permanent disability, as
evidenced by fatigue, limited exercise capacity and
a consequent negative impact on quality of life (QoL).3
Dyspnoea, the most common respiratory symptom, further
limits a patient’s physical activity, constraining him/her to
a sedentary lifestyle: altogether bringing about negative
feedback, in that the immobility causes a reduction in
muscular mass and forces the patient to become dyspnoeic
with ever decreasing levels of workload.
Pulmonary rehabilitation (PR) programmes are widely
recognised and accepted as an integral part of clinical treat-
ment as well as in the maintenance of the state of health for
patients with chronic respiratory disease who remain symp-
tomatic or continue to demonstrate reduced function despite
standard medical treatment.4 There are numerous studies in
the literature, carried out on an outpatient basis which
highlight PR as producing noteworthy improvements in dysp-
noea, exercise capacity andquality of life, even in a long term
stable COPD.5e10 However, in most of these studies carried
out on patients affected by a severe COPD, information about
respiratory failure was always very poor or totally neglected.
In addition, there are few studies which underscore the
benefits obtained from inpatient PR (IPR) programmes.11e13
Yet this lack of data does not inspire more study, as, it is
exactly in these more severe patients that neuromotor
compromise is commonplace, due as much to respiratory
dysfunction as to impairments of the muscle groups
(especially of the lower limbs), which also brings about
a significant increase in assisted care. This aspect has
seldom been studied, as the customary assessment
methods do not take it under sufficient consideration.
The aim of our preliminary study was to evaluate the
efficacy of IPR in COPD patients with respiratory failure
using the functional independence measure (FIM), interna-
tionally validated for documenting levels of neuromotor
disability and for tallying levels of everyday self sufficiency
amongst the studied patients14 in addition to the usual
exercise tolerance, dyspnoea index and QoL measurements.FIM: functional independence measure; FEV1: forced expiratory
volume in 1 s; PaO2: arterial oxygen tension; PaCO2: arterial
carbon dioxide tension; 6-MWT: 6-min walking test; MRC:
Medical Research Council dyspnoea scale (score from 1 to 5);
SGRQ: St. George’s Respiratory Questionnaire; LTOT: long term
oxygen therapy; CI: Charlson index adjusted for age; MV:
mechanical ventilation; NIMV: non-invasive mechanical venti-
lation; ICU: intensive care units; RICU: respiratory intensive
care units.Methods
Patients
The institutional review board approved the study purpose.
Procedures were conducted according to the declaration ofHelsinki, while all the patients gave their informed consent
to the study.
We examined 22 patients with RF due to COPD consec-
utively admitted to our 32-bed Pulmonary Rehabilitation
Unit from acute care hospitals (six sent from intensive care
units, eight sent from respiratory intensive care units and
eight from other medical wards). They were all bedridden,
and all of them were recovering from an acute episode of
acute respiratory failure. The validated Charlson index (CI)
adjusted for age was used to determine the degree of
comorbidity.15
Four of them had a tracheotomy and they were partially
weaned from mechanical ventilation. Diagnosis of COPD
had been confirmed according to the American Thoracic
Society (ATS) and European Respiratory Society (ERS)
guidelines.16 Population characteristics are described in
Table 1.
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The rehabilitation team consisted of a chest physician
director, a physical therapist, nurses, a psychologist and
a dietician. Subjects participated in five daily sessions each
week (3-h supervised sessions) up to a maximum of 20
(mean 18.2 sessions) during a hospital stay of 28 4 days.
The program included: (A) active limb mobilisations
which were performed with the patient lying down on
a physiotherapist table; (B) electrically induced contrac-
tions of the quadriceps which were performed five times
a week using a two-channel model electric stimulator (ES)
which generated bipolar, biphasic, symmetric rectangular
pulses. ES was used for >30 min on both legs simulta-
neously. (C) Supervised incremental exercise until the
patient achieved 30 min of continuous cycling at 70% of the
maximal workload achieved on an incremental cyclo-
ergometer test carried out at admission. This test was
a symptom-limited incremental exercise test and was per-
formed on an electrically braked cycloergometer using
a standard incremental cycle exercise protocol. EKG
activity was monitored continuously and the systemic
arterial blood pressure was registered every minute using
a sphygmomanometer. After a 2 min period of unloaded
pedalling, the load was increased by 10 W each minute and
the patients were encouraged to cycle to the point of
intolerable breathlessness, discomfort or exhaustion, until
the maximal heart rate was achieved, an abnormal EKG was
noted, or whenever the patient wanted to stop (symptom-
limited exercise test). (D) Daily abdominal muscle activi-
ties, inspiratory resistive sessions, full arm cycling as well
as twice a week educational sessions (covering topics such
as pulmonary physiopathology, pharmacology of patient’s
medications, dietary counselling, relaxation, energy
conservation principles) were conducted.
Measurements
Each outcome measure has been assessed at baseline (pre)
and at the end (post) of IPR. Measurements were taken by
personnel unaware of the study purposes.
Blood gas analysis
Arterial samples were taken from the radial artery while
the patient, breathing room air, was lying in bed in a supine
position for 20 min. Samples were analyzed using an AVL-
OMNI blood gas analyzer (Modula system; Roche Diagnostic
Corporation, Basel, Switzerland) to obtain arterial PO2,
PCO2 and pH.
Exercise capacity and dyspnoea
Patient’s exercise capacity was determined by means of the
6-MWD.17 Patients were instructed to walk at their fastest
pace to cover the longest possible distance over 6 min.
Oxygen saturation was continuously monitored using
a pulse oximeter (Pulsox 5 portable pulse oximeter; Min-
olta, Tokyo, Japan) finger probe. Portable supplementary
oxygen was supplied to keep oxygen saturation 90% with
the equipment carried by the respiratory therapist. Every
minute the patients were encouraged using standardised
phrases. Once familiar with the instructions the test wascompleted in a 50-m corridor. The distance walked was
recorded for analysis. Assessment for the level of dyspnoea
was carried out via a Medical Research Council (MRC) scale
(score from 1 e as best e to 5 e as worst) and the Borg CR10
scale18e20 which were proposed by the same staff member
who ensured full comprehension on the part of the patient.
Functional independence measure
Each patient was asked to complete a FIM question-
naire14,21 comprised of the following items: assessment of
personal care (nutrition, hygiene, dress, etc.), sphincter
control, mobility (transfer to bed, chair, toilet), locomotion
(walking, climbing stairs), communication (comprehension
and expression), and communication and social recognition
(interpersonal relations, problem solving and memory).
Each item was attributed a rating graded on seven levels
where 1e2 points constituted complete non-self suffi-
ciency, 3e5 points partial non-self sufficiency and 6e7 self
sufficiency. Scores 1e5 are those which comprise the
assistance of non-medical health-professionals (aides,
nurses, physical or respiratory therapists, etc.).
Quality of life
Because FIM constitutes a good indicator of patient need
for assistance, yet does not measure the handicap
(psychological impact, as well as communication and social
recognition impact of the disability, quality of life, patient
satisfaction), SGRQ (Italian version)22 was utilised to assess
the health related QoL.
Statistics
In order to test the influence of rehabilitation on the
subjects we applied the distribution free Wilcoxon signed
rank test. Such tests have proprieties that hold under
relatively mild assumptions regarding the underlying pop-
ulations from which the data are obtained. In particular,
distribution free methods forgo the traditional assumption
that the underlying populations are normal.
In order to evaluate the relationship between FIM, MRC
and life quality we have performed a Spearman rank
correlation test; its a distribution free test that determines
whether there is a monotonic relation between two vari-
ables. This is a test for correlation between a sequence of
pairs of values. Using ranks eliminates the sensitivity of the
correlation test to the function linking the pairs of values.
In particular, the standard correlation test is used to find
linear relations between test pairs, but the rank correlation
test is not restricted in this way.
In all statistical analyses, in consideration of a small
number sample, we use Monte Carlo procedures to calcu-
late empirical p values based on generating 10,000
permutations of the original layout, that guarantees with
95% confidence that the true p values belong to these
ranges. Monte Carlo methods can be used to obtain an
empirical p value that approximates the exact p value
without relying on an asymptotic distributional theory or
exhaustive enumeration. Often many test statistics do not
have a standard asymptotic distribution and if a standard
asymptotic distribution does exist, it may not be reliable in
realistic sample sizes.
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All the studied patients completed the IPR; data were
available in all subjects. Characteristics of the patients at
admission are shown in Table 1.
Outcomes of the IPR are shown in Table 2. At the end of
IPR there was a statistically significant improvement of FIM
in terms of the total score (p< 0.001), and in different
items such as that concerning self care (p< 0.001), mobility
(pZ 0.006), sphincter control (pZ 0.015), locomotion
(p< 0.001), and social recognition (pZ 0.027); an
improvement, yet not significant, was also noted in the
parameters regarding item communication. The usual
outcomes dealing with PR improved significantly and simi-
larly (see Table 2).
An inverse correlation betweenMRCand FIM (rZ0.5042,
pZ 0.016) was observed.
It should be pointed out that after PR no significant
change was achieved in terms of the spirometric parame-
ters and blood gas analysis (data not shown).
Discussion
Our study in a small group of patients suffering from COPD
and RF has shown that inpatient rehabilitation carried out
over 4 weeks is capable of improving the level of neuromotor
disability similarly as dyspnoea, exercise capacity and QoL.
While many authors have dealt with outpatient proto-
cols, we have referred to inpatient rehabilitation which, in
our opinion, better adapts to the needs (logistical/organi-
zational difficulties, familial and economic problems,
gravity of illness) of these patients with an advanced
disease. This choice was even supported by a recent study23
in which the authors demonstrated that a shorter inpatient
rehabilitation programme brought about the same benefits
in terms of exercise capacity as a longer term outpatient
programme, but with decidedly lower economic burdens.
Despite the mean FEV1 (see Table 1), our COPD patients
were likely to have a disability and a clear indication to PR;
this is almost the case of those COPD recovering from acute
exacerbation.13 Nonetheless, we would also claim attention
to the fact that all the included COPD patients also sufferedTable 2 Mean (m) and standard deviation (s) of the FIM scores p
standard deviation of the change
Parameters m s
Pre Post
FIM self-care 30.68 8.16 34.27 7.97
FIM sphincter control 10.55 4.02 11.59 3.5
FIM mobility 14.09 5.12 15.45 4.96
FIM locomotion 6.86 3.33 8.64 3.53
FIM communication 12.59 2.32 12.59 2.32
FIM social recognition 17.41 2.82 17.91 2.94
Total FIM 92.18 23.29 100.45 23.16
6-MWD 164.55 98.63 214.32 97.64
MRC 4.32 0.84 3 1.15
SGRQ 69.86 14.62 46.5 11.94
For abbreviations see Table 1.from CRF, which (as a systemic complication) may further
contribute to the patient’s disability.
In our study, we used MRC, the Borg CR10 scale and the
6-MWD test to assess dyspnoea and exercise capacity. These
indexes, already used by other authors in the same inpa-
tient regimen in this specific population stratum of patients
suffering from COPD and respiratory failure,24,25 have
demonstrated all the most positive characteristics e
simplicity, minimum demands upon resources and general
applicability.
In the present study we haven’t used the BODE index
which does capture the beneficial effects induced by
pulmonary rehabilitation.26
We have previously shown27 that BODE in severe and
elderly chronic obstructive pulmonary disease subjects with
chronic respiratory failure significantly improved after an
inpatient pulmonary rehabilitation programme. But in our
opinion this multidimensional index is not properly
designed to detect severe disability after an acute episode
in poorly independent patients. On the other hand FIM has
been developed to provide a more comprehensive assess-
ment of disability.
To assess the level of neuromotor dysfunction, it seemed
therefore worthwhile to use the FIM scale which was
conceived in the United States in the 1980s in response to
the need to document the gravity of disabling conditions and
the results of possible rehabilitative treatments. In 1984 and
in 1999 the National Institute on Disability and Rehabilitation
Research (NIDRR) together with the Department of Educa-
tion promoted the foundation and development of the
uniform data system for medical rehabilitation (UDSMR),21
for the development of the standardisation of measurement
in rehabilitation. From the time of its inception to today, FIM
has evolved dynamically and research on its validity has
passed all phases of pilot study, clinical study and revision,
allowing the characteristics of validity and reliability to be
assigned. During the last years this scale has undergone
several refinements, the most notable of which is the
weighting of individual scores using Rasch analysis, which
utilises log odd ratios of probability to make the intervals
between steps the same, thus allowing FIM to be used as an
interval scale. Thus, giving the FIM interval properties, it
allows it to be used statistically in order to measure there and post inpatient pulmonary rehabilitation and mean and
p value (between times) Change (m s)
0.001 3.59 3.16
0.015 1.05 2.44
0.006 1.36 2.32
0.001 1.77 1.27
n.s.
0.027 0.5 1.22
<0.001 8.27 8.36
<0.001 49.77 31.38
<0.001 1.32 0.84
<0.001 23.36 13.92
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used as an objective assessment of change both in rehabili-
tation research and in clinical trials.
This scale explores the functional areas of personal care,
sphincter control, mobility, locomotion, cognitive capacity
and interpersonal relationships, assigning to each a gradu-
ated score on a seven level scale. In the recent years, FIM
has been used almost exclusively by neuromotor rehabili-
tation centres to, for example, assess the precision of
recovery time frames in patients with cerebrovascular
pathologies like stroke,28,29 or to study functional
autonomy in elderly individuals over 80 years of age.30
Overall, the FIM score is an index of the gravity of
disability of the patient, which translates into a measure-
ment of the assisted care needed to reach a certain QoL.
Assisted care means consumption of social and economic
resources and therefore, cost of disability in socio-
economic terms. FIM captures functionalities which the
patient is truly capable of achieving, independently of the
underlying disability. However, since FIM does not directly
measure either the psychological and communication/
social recognition impact of the disability or the patient
satisfaction, and thus not measuring QoL, we have also
utilised SGRQ in our study. With regard to this we were able
to demonstrate that even in patients with chronic respira-
tory failure, this dimension improves after one cycle of IPR,
thus confirming previous data.8,31
Among the FIM items, locomotion was most positively
affected by the benefits of our programme. Indeed,
amongst the patients suffering from COPD with chronic
respiratory failure, whose care is becoming more compli-
cated and costly, neuromotor disability, understood as
a deficiency in ambulation, represents what is often the
main problem: in other words, these patients are forced
into immobility not only by dyspnoea, but also by other
potentially iatrogenic causes (steroid induced myopathy) as
well as by the fact that many of them are subject to long
term oxygen therapy (LTOT). Interestingly enough, the FIM
total score also has shown significant (although partial)
correlation with MRC, thus underlying the potential signif-
icance of this index in depicting a common pattern of
disability within the category of respiratory patients. In our
opinion the interpretation of this result is that when
a severe COPD patient shows a high disability, he/she at the
same time does experience the worst degree of dyspnoea
which does represent the key symptom in this complex
respiratory disease.
Therefore, the use of an indicator which presents good
reproducibility would be enormously helpful, provided
that it is rigorously collocated with other validated
indexes of pulmonary rehabilitation. The advantages to
its use also consist in the ability to predict a scheduled
discharge date for bedridden patients in rehabilitation
wards (residence rather than long term hospitalization)
and the relative home care assistance (minutes of assis-
tance/day). Lastly, the scale could be inserted, as done
in USA (functional related groups e FRG), as a prospec-
tive payment system appropriate to rehabilitative
hospital stays.14 It is useful to consider though, if inter-
ests lie exclusively in investigating mobility and capacity
for locomotion within COPD patients (items in which FIM
has been demonstrated to be most sensitive), that thereare other scales and indexes which are shorter and easier
to administrate (e.g. Barthel index). It is hoped,
however, that in the future FIM will find its role in the
evaluation of critical respiratory patients (i.e. those with
tracheotomies or oxygen therapy) in whom recovery time
is fundamental.
In conclusion, our study has confirmed the benefits of
inpatient pulmonary rehabilitation in COPD patients with
respiratory failure. These benefits translate not only into
improvements in symptoms, exercise capacity and quality
of life, but also within the neuromotor disabilities as
assessed by FIM.
Future studies will better clarify the role of the FIM scale
which must remain placed side by side with other interna-
tionally validated outcomes. At present its use in COPD
patients suffering from respiratory failure can be suggested
for collecting most information and for rendering it
contemporaneously accessible to physicians, physiothera-
pists and healthcare workers, thus optimizing their inter-
disciplinary work. Our findings warrant future studies in
pulmonary rehabilitation using FIM as an outcome measure.
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